[{"id":"a77130f6-4267-41cc-a05c-9e72830a4466","acronym":"","url":"https://clinicaltrials.gov/study/NCT05651191","created_at":"2022-12-14T14:58:25.990Z","updated_at":"2024-07-02T16:35:59.126Z","phase":"Phase 1","brief_title":"To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL","source_id_and_acronym":"NCT05651191","lead_sponsor":"Hrain Biotechnology Co., Ltd.","biomarkers":" IL6 • IL15","pipe":" | ","alterations":" CD19 positive","tags":["IL6 • IL15"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anti-CD19 DASH CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 10/21/2022","start_date":" 10/21/2022","primary_txt":" Primary completion: 09/30/2024","primary_completion_date":" 09/30/2024","study_txt":" Completion: 09/30/2025","study_completion_date":" 09/30/2025","last_update_posted":"2022-12-14"}]